Company Profile
T2 Biosystems Stock Price, News & Analysis
- Ticker:
- TTOO
- Exchange:
- NASDAQ
- Sector:
- MedTech
- Location:
- United States
Stock performance
0.00 USD (0.00%)
Close
Last updated: August 6, 2026
—
Market cap
Why the stock is moving
As of Aug 6, 2026, TTOO was little changed and closed at $0.0005. No new same-company headline was identified in the current news window.
Company overview
Business overview
T2 Biosystems is a medical diagnostics company focused on rapid pathogen detection and bloodstream infection testing. Its business is centered on delivering fast diagnostic information to clinical settings.
Geographic Base and Sector Classification
T2 Biosystems is headquartered in the United States and listed on NASDAQ. It sits in medical diagnostics rather than biotechnology therapeutics.
Business Model Characteristics
The company depends on test adoption, hospital utilization, and commercialization execution in a challenging diagnostics market. Investors usually watch sales, reimbursement, and operating discipline.
Position Within the Biotechnology Landscape
T2 Biosystems belongs to the diagnostics infrastructure layer of healthcare. It is not a drug developer, but it matters to clinical workflow because rapid testing can change treatment decisions.
Future catalysts
T2 Biosystems is a legacy / closeout story now, with catalysts limited to any strategic or asset-resolution update. There is no active standalone growth story left.
Recent news
- 01
- 02
- 03
- 04
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of T2 Biosystems (TTOO)?
T2 Biosystems (TTOO) most recently closed at 0.00 USD, a 0.00% move versus the previous session.
What does T2 Biosystems do?
T2 Biosystems is a medical diagnostics company focused on rapid pathogen detection and bloodstream infection testing. Its business is centered on delivering fast diagnostic information to clinical settings.
On which exchange is TTOO stock listed?
T2 Biosystems (TTOO) is associated with NASDAQ, United States, MedTech.
What is Biosystems?
T2 Biosystems is a legacy / closeout story now, with catalysts limited to any strategic or asset-resolution update.
Which conditions is T2 Biosystems targeting with Biosystems?
T2 Biosystems is a legacy / closeout story now, with catalysts limited to any strategic or asset-resolution update.
How does T2 Biosystems describe recent progress with Biosystems?
T2 Biosystems is a legacy / closeout story now, with catalysts limited to any strategic or asset-resolution update.
What is There?
There is no active standalone growth story left.
What should investors watch for with There?
There is no active standalone growth story left.